AAAAAA
Results:
1-12
|
Results: 12
Authors:
SORKNESS CA
Citation: Ca. Sorkness, ESTABLISHING A THERAPEUTIC INDEX FOR THE INHALED CORTICOSTEROIDS - PART II - COMPARISONS OF SYSTEMIC ACTIVITY AND SAFETY AMONG DIFFERENT INHALED CORTICOSTEROIDS, Journal of allergy and clinical immunology, 102(4), 1998, pp. 52-64
Authors:
MCGILL KA
SORKNESS CA
FERGUSONPAGE C
GERN JE
HAVIGHURST TC
KNIPFER B
LEMANSKE RF
BUSSE WW
Citation: Ka. Mcgill et al., ASTHMA IN NON-INNER CITY HEAD-START CHILDREN, Pediatrics (Evanston), 102(1), 1998, pp. 77-83
Authors:
SORKNESS CA
Citation: Ca. Sorkness, THE USE OF 5-LIPOXYGENASE INHIBITORS AND LEUKOTRIENE RECEPTOR ANTAGONISTS IN THE TREATMENT OF CHRONIC ASTHMA, Pharmacotherapy, 17(1), 1997, pp. 50-54
Authors:
LEMANSKE RF
SORKNESS CA
KUNSELMAN SJ
Citation: Rf. Lemanske et al., DIFFERENCES IN SKIN-TEST RESPONSES BETWEEN MINORITY AND NON-MINORITY PATIENTS WITH MILD ASTHMA IN A MULTICENTER CLINICAL-TRIAL, Journal of allergy and clinical immunology, 99(1), 1997, pp. 519-519
Authors:
STORMS W
HOWLAND WC
SORKNESS CA
LAFORCE C
GOLDSTEIN M
LINCOURT WR
ROGENES PR
SCHABERG AE
EDWARDS L
Citation: W. Storms et al., FLUTICASONE PROPIONATE (FP), TRIAMCINOLONE ACETONIDE (TAA) AND FLUNISOLIDE (FLN) HAVE SIMILAR EFFECTS ON THE HPA AXIS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1304-1304
Authors:
REISS TF
SORKNESS CA
STRICKER W
BOTTO A
BUSSE WW
KUNDU S
ZHANG J
Citation: Tf. Reiss et al., EFFECTS OF MONTELUKAST (MK-0476), A POTENT CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONIST, ON BRONCHODILATION IN ASTHMATIC SUBJECTS TREATED WITHAND WITHOUT INHALED CORTICOSTEROIDS, Thorax, 52(1), 1997, pp. 45-48
Authors:
MAILLOUX AT
GIDAL BE
SORKNESS CA
Citation: At. Mailloux et al., POTENTIAL INTERACTION BETWEEN WARFARIN AND DICLOXACILLIN, The Annals of pharmacotherapy, 30(12), 1996, pp. 1402-1407
Authors:
MCGILL KA
SORKNESS CA
LANNER A
SWENSON C
BUSSE WW
Citation: Ka. Mcgill et al., USE OF EOSINOPHIL CATIONIC PROTEIN AS A PREDICTIVE MARKER FOR EXACERBATIONS OF ASTHMA, Journal of allergy and clinical immunology, 97(1), 1996, pp. 511-511
Authors:
GIDAL BE
SORKNESS CA
MCGILL KA
LARSON R
LEVINE RR
Citation: Be. Gidal et al., EVALUATION OF A POTENTIAL ENANTIOSELECTIVE INTERACTION BETWEEN TICLOPIDINE AND WARFARIN IN CHRONICALLY ANTICOAGULATED PATIENTS, Therapeutic drug monitoring, 17(1), 1995, pp. 33-38
Authors:
GIDAL BE
SORKNESS CA
MCGILL KA
LARSEN RL
PITTERLE ME
LEVINE RF
Citation: Be. Gidal et al., EVALUATION OF A POTENTIAL ENANTIOSELECTIVE INTERACTION BETWEEN WARFARIN (W) AND TICLOPIDINE (T) IN CHRONICALLY ANTICOAGULATED PATIENTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 164-164
Authors:
SORKNESS CA
BUSH RK
Citation: Ca. Sorkness et Rk. Bush, ALTERNATIVES TO CORTICOSTEROIDS IN THE TREATMENT OF ASTHMA, Immunology and allergy clinics of North America, 13(4), 1993, pp. 917-938
Authors:
BROWN RA
SORKNESS RL
SORKNESS CA
BUSSE WW
Citation: Ra. Brown et al., RELATIONSHIP BETWEEN FEV(1) AND FEF25-PERCENT-75-PERCENT IN SUBJECTS DURING AN EXERCISE-INDUCED AIRWAY-OBSTRUCTION STUDY, The American review of respiratory disease, 147(4), 1993, pp. 558-558
Risultati:
1-12
|